SYDNEY BANACK: Open Payments
NPI 1871042333 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 21 payments from 13 companies in 2025. Trend: 2023 $872 · 2024 $404 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $136 |
| Boston Scientific Corporation | 3 | $88 |
| PFIZER INC. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Novo Nordisk Inc | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| CVRx, Inc. | 1 | $24 |
| AtriCure, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: LEQVIO, WATCHMAN FLX, VYNDAQEL, VERQUVO, EVKEEZA, Ozempic, OPSYNVI, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
